Balance Sheet

Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Medifast (MED) Amortization of Deferred Charges (2016 - 2022)

Medifast's Amortization of Deferred Charges history spans 5 years, with the latest figure at $3000.0 for Q2 2022.

For Q2 2022, Amortization of Deferred Charges changed N/A year-over-year to $3000.0; the TTM value through Mar 2023 reached $3000.0, down 99.27%, while the annual FY2022 figure was $14000.0, 84.27% down from the prior year.
Amortization of Deferred Charges reached $3000.0 in Q2 2022 per MED's latest filing, down from $11000.0 in the prior quarter.
In the past five years, Amortization of Deferred Charges ranged from a high of $153000.0 in Q1 2018 to a low of $3000.0 in Q2 2022.
Average Amortization of Deferred Charges over 3 years is $102000.0, with a median of $136000.0 recorded in 2018.
The largest YoY upside for Amortization of Deferred Charges was 12.18% in 2018 against a maximum downside of 21.39% in 2018.
A 3-year view of Amortization of Deferred Charges shows it stood at $137000.0 in 2018, then decreased by 5.84% to $129000.0 in 2019, then plummeted by 97.67% to $3000.0 in 2022.
Per Business Quant, the three most recent readings for MED's Amortization of Deferred Charges are $3000.0 (Q2 2022), $11000.0 (Q1 2022), and $129000.0 (Q1 2019).